A. Clement (Paris, France), A. Bianco (Napoli, Italy)
Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells S. Mizuno, Y. Demura, M. Wakabayashi, T. Ishizaki (Fukui, Japan)
| |
Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia: role of p38 MAP kinase U. S. Kayyali, C. Donaldson, H. Huang, R. Abdelnour, P. M. Hassoun (Boston, United States Of America)
| |
Protective role of PARP inhibitors in reperfusion/reoxygenation injury R. P. Strosznajder, R. Gadomski, G. Czapski, J. Strosznajder (Warsaw, Poland)
| |
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease A. Noguera, E. Sala, S. Batle, J. Iglesias, A. R. Pons, A. G. N. Agusti (Palma Mallorca, Spain)
| |
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers D. Miotto, P. Boschetto, C. Piola, I. Bononi, J. F. Evans, F. Rea, A. Zuin, A. Papi, L. M. Fabbri, C. E. Mapp (Ferrara, Padova, Modena, Italy; Dorval, Canada)
| |
Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis M. P. Ruggieri, D. Miotto, P. Boschetto, M. Padoan, F. Rea, A. Zuin, A. Papi, L. Zucchi, L. M. Fabbri, C. E. Mapp (Modena, Ferrara, Padova, Italy)
| |
Gene polymorphisms of immunregulatory cytokines and angiotensin-converting enzyme in wegener's granulomatosis G. Murakozy, K. I. Gaede, B. Ruprecht, O. Gutzeit, M. Schurmann, A. Schnabel, M. Schlaak, W. L. Gross, J. Muller-Quernheim (Budapest, Hungary; Borstel, Brad Bramstedt, Lübeck, Germany)
| |
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD P. Maestrelli, C. Paska, M. Saetta, G. Turato, S. Monti, B. Formichi, S. Baldi, M. Miniati, L. M. Fabbri (Padova, Pisa, Modena, Italy)
| |
Expression of cysteine proteases in sarcoidosis and tuberculosis F. Bühling, C. Röcken, A. Gerber, S. Ansorge, T. Welte (Magdeburg, Germany)
| |
Clinical severity of asthma. Can it be measured in sputum? N. L. Woodman, F. E. Woisin, M. W. Jensen, S. D. Greenaway, E. Staite, B. J. O'Connor, V. Kanabar (London, United Kingdom)
| |
Functional consequences of cathepsin L-deficiency in the human lung carcinoma cell line A549 A. Wille, A. Gerber, A. Reisenauer, S. Ansorge, T. Welte, F. Bühling (Magdeburg, Germany)
| |
Apoptosis of alveolar septal cells contributes to the pathogenesis of emphysema N. F. Voelkel, R. M. Tuder, M. W. Geraci, H. A. Golpon, L. Taraseviciene-Steward, S. Flores, Y. Kasahara (Denver, United States Of America)
| |
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters G. Urpek, C. Yenisey, A. Komurcuoglu, G. Tibet (Izmir, Aydin, Turkey)
| |
The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls S. Hasturk, M. Karatas, I. Hanta, R. Burgut (Adana, Turkey)
| |
Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis V. L Kinnula, S. Lehtonen, R. Kaarteenaho-Wiik, E. Lakari, P. Paakko, S. W. Kang, S. G. Rhee, Y. Soini (Oulu, Finland; Bethesda, United States Of America)
| |
VEGF mRNA response to exercise in chronic heart failure and COPD P. D. Wagner, R. S. Richardson, O. Mathieu-Costello, H. Wagner, T. P. Gavin, F. Esposito (La Jolla, United States Of America)
| |